Local Institution
Cuernavaca, Morelos 62448
0 studies enrolling now · 17 studies all time
What they study most
Chronic Hepatitis B, Chronic Kidney Failure, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes, Type 2, Hepatitis C, Hepatitis C Virus, Kidney Transplantation, Liver Cancer, Prostate Cancer, Renal Transplant
Studies at this site
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
- Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment — Completed
- Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
- A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids — Completed
- A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
- Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
- Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes — Completed
- Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment — Completed
- A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas — Completed
- A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
- Belatacept Pharmacokinetic Trial in Renal Transplantation — Completed
- A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
- PPAR - Combination With Metformin — Completed
- Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed
- Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
- A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed